In a recent earnings call, Pulse Biosciences, Inc. (NASDAQ:) outlined significant advancements in developing its nano-Pulse Field Ablation (nano-PFA) devices and provided financial updates for the second quarter of 2024. The company’s President and CEO, Burke T. Barrett, highlighted the transformative potential of nano-PFA technology for treating various diseases and…